Study to Explore the Onset of Efficacy on Magnetic Resonance Disease Activity of BG00012 (Dimethyl Fumarate) in Patients With Relapsing remitTing Multiple Sclerosis

NCT02472938 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Sponsor Decision

Conditions

Relapsing Remitting Multiple Sclerosis

Interventions

DRUG: dimethyl fumarate
OTHER: Placebo

Sponsor

Biogen

Collaborators

[object Object]